Nonin

Executive Summary

Nonin Medical, founded in 1986 and headquartered in Minneapolis, is a privately held leader in noninvasive patient monitoring, specializing in pulse oximeters and regional oximeters for clinical and home settings. With a reputation for accuracy and durability, Nonin's devices are trusted by clinicians worldwide to deliver actionable data. The company has consistently focused on innovation in sensor technology and form factors, maintaining a strong presence in hospitals, ambulatory care, and increasingly in home healthcare. As digital health and remote monitoring expand, Nonin is well-positioned to leverage its expertise in reliable, noninvasive monitoring solutions. Nonin's market opportunity is driven by the growing demand for home-based care and wearable monitoring. The company is expected to continue evolving its product line to include wireless and connected devices that integrate with digital health platforms. With a long history of quality and a loyal customer base, Nonin’s strategic focus on innovation and partnerships could unlock new growth avenues. However, as a private company with limited public disclosures, near-term catalysts may hinge on new product clearances or collaborations that further penetrate the remote patient monitoring market.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for Next-Generation Wearable Pulse Oximeter70% success
• Q2 2027Strategic Partnership with Major Telehealth Platform50% success
• Q3 2026Launch of Cloud-Based Remote Patient Monitoring Platform60% success